Drug interactions
Copper cu 64 dotatate + Octreotide
Severity: Moderate
Copper cu 64 dotatate and Octreotide: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Octreotide binds the same somatostatin receptors targeted by the Cu 64 dotatate radiotracer and can reduce tracer uptake in tumors. This may lower PET image quality and sensitivity for detecting lesions.
What this interaction means in plain words
Copper cu 64 dotatate and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Competitive binding at somatostatin receptors (mainly subtype 2) reduces radiotracer uptake.
What to do
Schedule PET imaging just before the next dose of long-acting octreotide, and withhold long-acting formulations for about 4 weeks and short-acting for about 2 days before imaging where clinically feasible.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Copper cu 64 dotatate and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Octreotide
Frequently asked questions
Can I take Copper cu 64 dotatate with Octreotide?
MediHelp rates the interaction as moderate. Copper cu 64 dotatate and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Octreotide binds the same somatostatin receptors targeted by the Cu 64 dotatate radiotracer and can reduce tracer uptake in tumors. This may lower PET image quality and sensitivity for detecting lesions.
How serious is the interaction between Copper cu 64 dotatate and Octreotide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Schedule PET imaging just before the next dose of long-acting octreotide, and withhold long-acting formulations for about 4 weeks and short-acting for about 2 days before imaging where clinically feasible.
What other medicines interact with Octreotide?
MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
